tiprankstipranks
Trending News
More News >
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
Advertisement

Unicycive Therapeutics (UNCY) Technical Analysis

Compare
717 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Unicycive Therapeutics’s (UNCY) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Unicycive Therapeutics is a Sell.
Unicycive Therapeutics’s (UNCY) 20-Day exponential moving average is 4.49, while Unicycive Therapeutics’s (UNCY) share price is $4.8, making it a Buy.
Unicycive Therapeutics’s (UNCY) 50-Day exponential moving average is 4.47, while Unicycive Therapeutics’s (UNCY) share price is $4.8, making it a Buy.

Unicycive Therapeutics (UNCY) Pivot Points

Oct 18, 2025, 11:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.43
4.52
4.66
4.75
4.89
4.98
5.12
Fibonacci
4.52
4.61
4.66
4.75
4.84
4.89
4.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Unicycive Therapeutics (UNCY) Moving Averages

Oct 18, 2025, 11:43 AM
Period
Simple
Exponential
MA5
4.64Buy
4.73Buy
MA10
4.66Buy
4.63Buy
MA20
4.38Buy
4.49Buy
MA50
4.28Buy
4.47Buy
MA100
4.95Sell
4.78Buy
MA200
5.50Sell
5.28Sell
Unicycive Therapeutics’s (UNCY) 10-Day exponential moving average is 4.63, while Unicycive Therapeutics’s (UNCY) share price is $4.8, making it a Buy.
Unicycive Therapeutics’s (UNCY) 100-Day exponential moving average is 4.78, while Unicycive Therapeutics’s (UNCY) share price is $4.8, making it a Buy.
Unicycive Therapeutics’s (UNCY) stock price is $4.8 and Unicycive Therapeutics’s (UNCY) 50-day simple moving average is 4.28, creating a Buy signal.
Unicycive Therapeutics’s (UNCY) stock price is $4.8 and Unicycive Therapeutics’s (UNCY) 100-day simple moving average is 4.95, creating a Sell signal.
Unicycive Therapeutics’s (UNCY) stock price is $4.8 and Unicycive Therapeutics’s (UNCY) 200-day simple moving average is 5.50, creating a Sell signal.

Unicycive Therapeutics (UNCY) Technical Indicators

Oct 18, 2025, 11:43 AM
Name
Value
Implied Action
RSI (14)
66.46
Neutral
STOCH (9,6)
63.29
Neutral
STOCHRSI (14)
79.03
Neutral
MACD (12,26)
0.15
Sell
ADX (14)
23.35
Neutral
Williams %R
-29.93
Buy
CCI (14)
143.42
Sell
ATR (14)
0.30
-
Ultimate Oscillator
51.25
Neutral
ROC
22.64
Buy
Unicycive Therapeutics’s (UNCY) Relative Strength Index (RSI) is 66.46, creating a Neutral signal.
Unicycive Therapeutics’s (UNCY) Trend Strength Indicator (ADX) is 23.35, creating a Neutral signal.
Unicycive Therapeutics’s (UNCY) Commodity Channel Index (CCI) is 143.42, creating a Sell signal.
Unicycive Therapeutics’s (UNCY) Price Rate of Change (ROC) is 22.64, creating a Buy signal.

FAQ

Is UNCY a Buy, Hold, or Sell?
Based on UNCY’s technical indicators, UNCY is a Buy.
    What is UNCY’s RSI (14)?
    UNCY’s RSI (14) is 66.46, which suggests UNCY is a Neutral.
      What is UNCY’s MACD?
      UNCY’s MACD is 0.15, which suggests UNCY is a Sell.
        What is UNCY’s 5-day moving average?
        UNCY’s 5-day moving average is 4.64, which suggests UNCY is a Buy.
          What is UNCY’s 20-day moving average?
          UNCY 20-day moving average is 4.38, which suggests UNCY is a Buy.
            What is UNCY’s 50-day moving average?
            UNCY’s 50-day moving average is 4.28, which suggests UNCY is a Buy.
              What is UNCY’s 200-day moving average?
              UNCY’s 200-day moving average is 5.50, which suggests UNCY is a Sell.
                What is UNCY’s Williams % R (14)?
                UNCY’s Williams % R (14) is -29.93, which suggests UNCY is a Buy.
                  What is UNCY’s CCI (14)?
                  UNCY’s CCI (14) is 143.42, which suggests UNCY is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis